A Study of the Effectiveness of Cabozantinib in Combination With Nivolumab as First-line Treatment of Advanced Renal Cell Carcinoma (aRCC) in Adults

NCT05361434 · clinicaltrials.gov ↗
ACTIVE_NOT_RECRUITING
Status
311
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

Ipsen